Skip to main content
. 2017 Jul 5;14(3):2783–2788. doi: 10.3892/ol.2017.6522

Table III.

Relationship between XRCC1-194 gene polymorphism and clinical characteristics of HCC.

XRCC1-194 (n, %)

Clinical features CC CT TT χ2 P-value
General types 0.653 0.957
  Giant block type 30 (54.55) 4 (7.27) 21 (38.18)
  Nodular type 27 (54.00) 3 (6.00) 20 (40.00)
  Diffuse type 38 (56.72) 6 (8.96) 23 (34.33)
No. of tumors 8.621 0.013
  Single tumor 83 (57.24) 7 (4.83) 55 (37.93)
  Multiple tumors 12 (44.44) 6 (22.22) 9 (33.33)
Liver tumor location 10.149 0.038
  Left lobe 42 (53.16) 5 (6.33) 32 (40.51)
  Right lobe 38 (55.07) 3 (4.35) 28 (40.58)
  Other 15 (62.50) 5 (20.83) 4 (16.67)
Tumor diameter 10.432 0.034
  <5 cm 42 (52.50) 5 (6.25) 33 (41.25)
  5-10 cm 43 (56.58) 4 (5.26) 29 (38.16)
  >10 cm 10 (62.50) 4 (25.00) 2 (12.50)
Capsule invasion 2.239 0.327
  Yes 32 (53.33) 7 (11.67) 21 (35.00)
  No 63 (56.25) 6 (5.36) 43 (38.39)

XRCC1, X-ray repair cross-complementing 1; HCC, hepatocellular carcinoma.